Next Article in Journal
Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer
Next Article in Special Issue
Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains
Previous Article in Journal
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Previous Article in Special Issue
Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors
 
 
Editorial

Article Versions Notes

Pharmaceutics 2019, 11(10), 541; https://doi.org/10.3390/pharmaceutics11100541
Action Date Notes Link
article xml file uploaded 17 October 2019 16:38 CEST Original file -
article pdf uploaded. 17 October 2019 16:38 CEST Version of Record https://www.mdpi.com/1999-4923/11/10/541/pdf-vor
article xml file uploaded 23 October 2019 11:52 CEST Update -
article xml uploaded. 23 October 2019 11:52 CEST Update https://www.mdpi.com/1999-4923/11/10/541/xml
article pdf uploaded. 23 October 2019 11:52 CEST Updated version of record https://www.mdpi.com/1999-4923/11/10/541/pdf
article html file updated 23 October 2019 11:54 CEST Original file -
article html file updated 30 October 2019 23:14 CET Update -
article html file updated 14 February 2020 01:51 CET Update https://www.mdpi.com/1999-4923/11/10/541/html
Back to TopTop